ST3GAL2 and Parkinson disease: In addition to the altered GM1 ganglioside levels in PD patients, the lower expression levels of the ganglioside biosynthetic enzymes, including GM1 synthase (B3GALT4) and GD1a/GT1b synthase (ST3GAL2), were demonstrated in substantia nigra of PD patients [11, 21].